Jessica L Christenson

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Breast Cancer Cells

Radical Prostatectomy

Endoplasmic Reticulum

Top Venues

Cancer research

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Wei Kuo, Lyndsey S Crump, Kathleen I O'Neill, Michelle M Williams, Jessica L Christenson, Nicole S Spoelstra, Micaela Kalani Roy, Amy Argabright, Julie A Reisz, Angelo D'Alessandro, Meher Preethi Boorgula, Andrew E Goodspeed, Mike Bickerdike, Benjamin G Bitler, Jennifer K Richer
Blocking tryptophan catabolism reduces triple-negative breast cancer invasive capacity. Cancer research communications (2024)
Natalia B Fernández, Sofía M Sosa, Justin T Roberts, María S Recouvreux, Luciana Rocha-Viegas, Jessica L Christenson, Nicole S Spoelstra, Facundo L Couto, Ana R Raimondi, Jennifer K Richer, Natalia Rubinstein
RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer. Cells 12 (3) (2023)
Natalia B Fernández, Sofía M Sosa, Justin T Roberts, María S Recouvreux, Luciana Rocha-Viegas, Jessica L Christenson, Nicole S Spoelstra, Facundo L Couto, Ana R Raimondi, Jennifer K Richer, Natalia Rubinstein
RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer. Cells 12 (3) (2023)
Natalia B Fernández, Sofía M Sosa, Justin T Roberts, María S Recouvreux, Luciana Rocha-Viegas, Jessica L Christenson, Nicole S Spoelstra, Facundo L Couto, Ana R Raimondi, Jennifer K Richer, Natalia Rubinstein
RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer. Cells 12 (3) (2023)
Natalia B Fernández, Sofía M Sosa, Justin T Roberts, María S Recouvreux, Luciana Rocha-Viegas, Jessica L Christenson, Nicole S Spoelstra, Facundo L Couto, Ana R Raimondi, Jennifer K Richer, Natalia Rubinstein
RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer. Cells 12 (3) (2023)
Natalia B Fernández, Sofía M Sosa, Justin T Roberts, María S Recouvreux, Luciana Rocha-Viegas, Jessica L Christenson, Nicole S Spoelstra, Facundo L Couto, Ana R Raimondi, Jennifer K Richer, Natalia Rubinstein
RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer. Cells 12 (3) (2023)
Faye A Camp, Tonya M Brunetti, Michelle M Williams, Jessica L Christenson, Varsha Sreekanth, James C Costello, Zachary L Z Hay, Ross M Kedl, Jennifer K Richer, Jill E Slansky
Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8 + T Cell Immunity. Cancers 14 (18) (2022)
Michelle M Williams, Sabrina A Hafeez, Jessica L Christenson, Kathleen I O'Neill, Nia G Hammond, Jennifer K Richer
Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Jessica L Christenson, Kathleen I O'Neill, Michelle M Williams, Nicole S Spoelstra, Kenneth L Jones, G Devon Trahan, Jordan Reese, Elaina T Van Patten, Anthony D Elias, Joel R Eisner, Jennifer K Richer
Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast Cancer. Molecular cancer therapeutics 20 (6) (2021)
Michelle M Williams, Nicole S Spoelstra, Spencer Arnesen, Kathleen I O'Neill, Jessica L Christenson, Jordan Reese, Kathleen C Torkko, Andrew Goodspeed, Emmanuel Rosas, Toru Hanamura, Sharon B Sams, Zheqi Li, Steffi Oesterreich, Rebecca B Riggins, Britta M Jacobsen, Anthony D Elias, Jason Gertz, Jennifer K Richer
Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer. Cancer research 81 (3) (2020)